• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX23
Device Problems Migration or Expulsion of Device (1395); Material Deformation (2976)
Patient Problem Low Cardiac Output (2501)
Event Date 11/28/2022
Event Type  Injury  
Event Description
As reported, it was a case of an implant of 23mm edwards sapien 3 transcatheter heart valve, in aortic position by transfemoral approach.The valve was fully deployed at the intended position; however, post-dilatation was needed due to moderate pvl.During post-dilatation, the 23mm sapien 3 valve move into the left ventricle.Another valve was implanted due to low cardiac output.On post-operative day 1, the first valve was explanted.No patient injury.Patient outcome was good post-procedure.It was noted that the valve was deformed due to post-dilatation.
 
Manufacturer Narrative
The investigation is ongoing.The device is not returning.
 
Manufacturer Narrative
This is one of two manufacturer reports being submitted for this case.Please reference related manufacturer report no: 2015691-2022-10293.
 
Manufacturer Narrative
Correction to section h6.The valve was not returned to edwards lifesciences for evaluation.In addition, no relevant imagery was provided for review.A device history review (dhr) was performed and did not reveal any manufacturing nonconformance that would have contributed to this complaint event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.A review of the risk management documentation was performed, and the reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaints were unable to be confirmed as no imagery/medical record was provided for evaluation.A review of dhr did not indicate any manufacturing nonconformance that could have contributed to the reported event.A review of ifu/training materials revealed no deficiencies.It was reported ''the balloon guidewire was wrongly positioned through valve cells instead of valve lumen resulting in valve embolization when the balloon was inflated.The valve was deformed due to post-dilatation''.Due to the post-dilation at the incorrect position, the valve frame was deformed, and disloged; subsequently, it was push toward the ventricle resulting in embolization.Available information suggests that procedural factors (post-dilation with incorrect guidewire position) may have contributed to the reported events.Since no manufacturing non-conformances or labeling/ifu/training deficiencies were identified, no product non-conformance was confirmed, and the complaint occurrence rate did not exceed the applicable trending control limit, no corrective/preventative actions nor product risk assessment (pra) escalation are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAPIEN 3 TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16017018
MDR Text Key305833062
Report Number2015691-2022-10179
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 01/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9600TFX23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-